Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, North York, OntarioDr. Peter Lin, a primary care physician, is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and has two busy family medicine practices in Toronto. For 7 years, he served as the medical director at the University of Toronto Scarborough Health & Wellness Centre. In 2011, he received a teaching award from the College of Family Physicians of Canada.
Dr. Lin has worked with KDIGO (Kidney Disease│Improving Global Outcomes) in an effort to help enhance care for patients with chronic kidney disease. He has been a contributing author to the Canadian Diabetes Guidelines and has served on the editorial board of Pri-Med Institute, which provides education for physicians.
Dr. Lin maintains an active lecture schedule, reflecting his varied medical interests, continuing his focus on bridging the chasm between research and clinical practice.
Disclosures
- Consultant (continuing medical education programs): AstraZeneca; Boehringer Ingelheim; Bayer; Eli Lilly; Amgen; Janssen; Merck; Pfizer; Sanofi; Abbott; HLS Therapeutics
Recent Contributions to PracticeUpdate:
- SGLT2 Inhibitors and GLP-1 Receptor Agonists for T2D
- Early High-Titer Plasma Therapy to Prevent Severe COVID-19 in Older Adults
- Association of Cumulative Systolic BP With Long-Term Risk of CVD and Healthy Longevity
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- Association of First Primary Cancer With Risk of Subsequent Primary Cancer Among Survivors of Adult-Onset Cancers
- REGN-COV2 Reduces Viral Load in COVID-19 Patients
- The Advisory Committee on Immunization Practices' Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine
- First-Line Drug Treatment for Hypertension According to Age and Ethnicity
- Efficacy and Safety of Lowering LDL Cholesterol in Older Patients
- Time to Benefit of Statin Therapy for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years